Home/Filings/4/0000899243-18-015478
4//SEC Filing

FRALEY ROBERT T 4

Accession 0000899243-18-015478

CIK 0001110783other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 4:55 PM ET

Size

25.7 KB

Accession

0000899243-18-015478

Insider Transaction Report

Form 4
Period: 2018-06-07
FRALEY ROBERT T
EVP, Chief Technology Officer
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-06-0733,2400 total
    Exercise: $112.82Common Stock (33,240 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-06-0749,2700 total
    Exercise: $91.34Common Stock (49,270 underlying)
  • Disposition to Issuer

    Common Stock

    2018-06-0718,9400 total(indirect: By Trust)
  • Disposition to Issuer

    Common Stock

    2018-06-0722,1390 total
  • Disposition to Issuer

    Common Stock

    2018-06-0741,8630 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-06-0741,4500 total
    Exercise: $90.48Common Stock (41,450 underlying)
  • Disposition to Issuer

    Common Stock

    2018-06-0717,2190 total
  • Disposition to Issuer

    Common Stock

    2018-06-0715,0000 total(indirect: By Trust)
  • Disposition to Issuer

    Common Stock

    2018-06-074,0210 total(indirect: By 401(k))
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-06-0735,3700 total
    Exercise: $106.05Common Stock (35,370 underlying)
  • Disposition to Issuer

    Phantom Share Units

    2018-06-077,1930 total
    Common Stock (7,193 underlying)
Footnotes (5)
  • [F1]Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").
  • [F2](Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
  • [F3]Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.
  • [F4]Represents restricted stock units.
  • [F5]Represents performance-based restricted stock units.

Issuer

MONSANTO CO /NEW/

CIK 0001110783

Entity typeother

Related Parties

1
  • filerCIK 0001083209

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:55 PM ET
Size
25.7 KB